Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-20

Clinical Trial Update: Safety and Pharmacokinetics Study of FBF001 [Phase 1]

View source ↗

Summary

Fab'entech's Phase 1 safety and pharmacokinetics study of FBF001 for Avian Influenza has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FBF001

Snippet

Sponsor: Fab'entech | Conditions: Avian Influenza | Phase 1 | Status: COMPLETED